Stay updated on FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial

Sign up to get notified when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page presents details of the Phase I FT596 study for relapsed or refractory B-cell lymphoma and chronic lymphocytic leukemia, including its design, eligibility criteria, outcomes, and locations. The record indicates that the sponsor terminated the study and it is no longer recruiting participants.
    Difference
    78%
    Check dated 2026-11-08T13:19:10.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the FT596 Phase 1 study record, including its terminated status, eligibility criteria, treatment arms, outcomes, locations, and study dates, instead of an access error.
    Difference
    78%
    Check dated 2026-11-01T14:09:27.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-25T13:35:19.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label updates from v3.7.1 to v3.7.2. The page otherwise remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:07:42.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:06:37.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with the standard header and navigation, replacing the usual study content and indicating restricted access to the study record. This reflects a change in how the page handles requests for this study record.
    Difference
    22%
    Check dated 2026-09-20T12:32:36.000Z thumbnail image

Stay in the know with updates to FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.